第一单位：
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cadiz, Spain.
作者：
Anaid,Pérez-Ramos [1]
;
Àlex,Gonzalez-Segura [2]
;
Laura,Julià [3]
;
Clemente,García-Rizo [4]
;
Ana,Sánchez-Torres [5]
;
Vito,Cavone [6]
;
Iñaki,Zorrilla [7]
;
Anna,Mané [8]
;
Roberto,Rodriguez-Jimenez [9]
;
Alexandra,Roldan [10]
;
Edith,Pomarol-Clotet [11]
;
Angela,Ibañez [12]
;
Judith,Usall [13]
;
Antonio,Lobo [14]
;
Miquel,Bioque [4]
;
Miquel,Bernardo [15]
;
Manuel J,Cuesta [16]
;
Mara,Parellada [6]
;
Ana,González-Pinto [7]
;
Esther,Berrocoso [17]
;
Silvia,Amoretti [18]
;
Gisela,Mezquida [19]
;
2EPs Working Group ;
Members of 2EPs Working Group
作者单位：
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cadiz, Spain.
[1]
Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
[2]
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
[3]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.
[4]
Department of Health Sciences, Universidad Pública de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain.
[5]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.
[6]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; BIOARABA, Department of Psychiatry, Hospital Universitario de Alava, UPV/EHU, Vitoria, Spain.
[7]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Grup MERITT, Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Barcelona, Spain.
[8]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Universidad Complutense de Madrid (UCM), Spain; Department of Psychiatry, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
[9]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Psychiatry Department, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain.
[10]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
[11]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Psychiatry, Hospital Universitario Ramon y Cajal, Universidad de Alcala, Instituto Ramon y Cajal de Investigacion Sanitaria (IRYCIS), Madrid, Spain.
[12]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Etiopatogènia i tractament dels trastorns mentals greus (MERITT), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain; Parc Sanitari Sant Joan de Déu, Doctor Antoni Pujadas, Sant Boi de Llobregat, Spain.
[13]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Department of Medicine and Psychiatry, Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
[14]
Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Emeritus Consultant, Barcelona Clínic Schizophrenia Unit, Hospital Clínic of Barcelona, Barcelona, Spain.
[15]
Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Spain; Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
[16]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Neuropsychopharmacology and Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cadiz, Spain; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Research Unit, Puerta del Mar University Hospital, Cádiz, Spain.
[17]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
[18]
Centre for Biomedical Research in Mental Health (CIBERSAM), ISCI-III, Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Serra-Hunter Lecturer Fellow, Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain. Electronic address: mezquida@recerca.clinic.cat.
[19]
DOI
10.1016/j.sjpmh.2025.08.002
PMID
41242552
发布时间
2025-12-03
换一批
